INTRODUCTION
As the fundamental repeating unit of chromatin, the nucleosome is a hub of genetic activity in the eukaryotic nucleus. This activity involves interactions of chromatin factors and enzymes with not just the individual histone and DNA components of the nucleosome but with the nucleosome as a unit (McGinty & Tan, 2016) . Despite the fundamental importance of such interactions to eukaryotic biology, we currently possess only a limited view of the molecular details of nucleosome interactions due to the relatively few three-dimensional structures available (Armache, Garlick, Canzio, Narlikar, & Kingston, 2011; Barbera et al., 2006; Kato et al., 2013; Makde, England, Yennawar, & Tan, 2010; Maskell et al., 2015; McGinty, Henrici, & Tan, 2014; Zhou et al., 2015) . Remedying this deficiency will require determining atomic structures of different classes of chromatin factors and enzymes with the nucleosome so that paradigms for chromatin interactions can be elucidated. We present here procedures for the crystal structure determination of chromatin complexes with special attention to preparing such complexes, applicable to other structural methods including cryoelectron microscopy, and postcrystallization soaks to improve crystal diffraction quality.
The basic workflow involved in the crystal structure determination of a chromatin complex is shown in Fig. 1 , and each item except for structure determination is discussed here (there are few aspects of crystal structure determination which are specific to chromatin complexes). The linear form of this ideal workflow does not, of course, reflect the reality of most projects where practical issues force one to proceed in a decidedly nonlinear fashion, for example, to redesign chromatin protein or nucleosome constructs. Crystallizing chromatin complexes remains a challenging endeavor, and it is the unusual chromatin complex project that progresses smoothly through purification, concentration, crystallization, diffraction studies, and structure determination. However, the substantial biological insights afforded provide compelling justification to pursue such structural studies.
PREPARE NUCLEOSOME CORE PARTICLES
The preparation of recombinant nucleosome core particles (NCPs) appropriate for structural studies has been described in detail in previous publications (Luger, Rechsteiner, & Richmond, 1999a , 1999b Luger, Rechsteiner, Flaus, Waye, & Richmond, 1997) , and these descriptions are still comprehensive and appropriate today. The reader is encouraged to follow closely the procedures described in these publications since the details can determine both the efficiency and quality of the resulting nucleosomes. We offer here some observations based on our experiences, which we hope will augment the descriptions in these publications. 1. We prefer to use anion-exchange high-performance chromatography over preparative gel electrophoresis to purify the reconstituted NCPs for the scalability and throughput advantages. While preparative gel electrophoresis could offer higher resolution purification, we
have not yet encountered situations that require such potential higher resolution. 2. We use GE Healthcare Source 15Q resin for the anion-exchange purification of reconstituted NCPs and find this resin to be at least as good as the Tosoh TSK DEAE-5PW employed in the Luger et al. publications (Luger, Rechsteiner, et al., 1997; Luger et al., 1999a Luger et al., , 1999b ). Although we have not evaluated the GE Healthcare Mono Q resin for purifying reconstituted nucleosomes, we suspect this resin would also be appropriate based on our other comparisons of Source Q and Mono Q resins. 3. We routinely evaluate Source Q fractions of reconstituted NCPs by native polyacrylamide gel electrophoresis (PAGE), but one has to be careful in interpreting the results since the peak fractions will contain significant concentrations of salt, which promote dissociation of the NCPs during electrophoresis. For a more accurate assessment of NCP quality, samples should be dialyzed against the storage low salt buffer before electrophoresis. Otherwise, the amount of free DNA and noncanonical nucleosome species might be overestimated. 4. The choice of the nucleosomal DNA to reconstitute with histones may be dependent on whether the associated chromatin factor or enzyme has any sequence preference. In the case that the chromatin factor or enzyme has no sequence preference, one could use the symmetric human alpha satellite nucleosome positioning sequence used successfully to crystallize the NCP at 1.9 Å resolution (Davey, Sargent, Luger, Maeder, & Richmond, 2002; Richmond & Davey, 2003) . However, one should be aware that preparing a symmetric nucleosome positioning sequence requires significantly more effort than preparing an asymmetric nucleosome positioning sequence (four preparative enzymatic steps vs just one). We have successfully used the asymmetric Widom 601 nucleosome positioning sequence used extensively in the chromatin field for our structural studies (Kim, Chatterjee, Jennings, Bartholomew, & Tan, 2015; Lowary & Widom, 1998; Makde et al., 2010; McGinty et al., 2014; Thåstr€ om et al., 1999) , and we observe slightly higher NCP reconstitution yields using this sequence. One potential disadvantage is a lower yield of plasmid containing multiple inserts of the Widom 601 DNA sequence: typically, a 12 L preparation of pST55-16xNCP601a (a high copy number plasmid containing 16 copies of a 147 bp Widom DNA repeat) provides 50-100 mg of plasmid, which yields 20-50 mg of the 147 Widom DNA repeat. Comparable yields for other asymmetric nucleosome positioning sequences can be twice as high. 5. The plasmid containing multiple inserts of the nucleosome positioning sequence should be propagated in the HB101 Escherichia coli strain for the recA genotype to reduce recombination of the relatively unstable plasmid. Even when using HB101, one may notice a small fraction of plasmid with less than the full number of inserts, but inserts appear to be lost as individual units and not fractions of an insert. 6. For crystallizing chromatin complexes, it is helpful to have minimally 3-5 mg of purified NCPs at a concentration of $10 mg/mL.
PREPARE CHROMATIN PROTEIN
It is difficult to provide general instructions on how to prepare chromatin proteins since each protein is highly individual. Seeing that one will need milligram quantities of the chromatin protein, recombinant methods are often used to overexpress the individual protein or protein complex in an appropriate heterologous system. Standard approaches should be used to express and purify the protein (Burgess & Deutscher, 2009; Coligan et al., 1995) . We try to prepare at least 5 mg of protein at a final concentration of >5 mg/mL in an appropriate buffer, with higher concentrations required for larger proteins and complexes and those requiring high salt for concentration. The concentration buffer conditions are optimized to reduce aggregation of the concentrated protein. We use dynamic light scattering (DLS) to assess the aggregation state (we strive for a single peak with a polydispersity of <20%). We also aim for a purity of >95%, noting that the chromatin protein does not need to be absolutely pure since further purification of the chromatin protein/nucleosome complex will be carried out (see item 4 below).
PURIFY CHROMATIN COMPLEX

Analytical Purification
We prefer to use size exclusion chromatography to purify the chromatin protein or enzyme in complex with the nucleosome (the complex will be referred to as the "chromatin complex") for several reasons. Size exclusion chromatography is a relatively robust and simple method, it is scalable (enabling both analytical and preparative uses), and the buffer exchange properties allow samples to be concentrated immediately after the run.
Preparative electrophoresis of the chromatin complex is an alternative that may be particularly useful if overlapping chromatography peaks of different complexes can be resolved by electrophoresis. We do note that not all chromatin complexes stable to size exclusion chromatography will be stable to electrophoresis. Selective precipitation with polyethylene glycol is yet another alternative purification method for chromatin complexes (Arnaudo et al., 2013) .
In order to ensure stoichiometric preparations of chromatin complexes, we first optimize reconstitution buffer, especially salt concentration, and chromatin protein/nucleosome ratios using analytical scale reconstitutions prior to proceeding to preparative scales. An example of this optimization is described here.
1. Equilibrate a Superdex 200 column in filtered MilliQ water at a flow rate of 0.2-0.4 mL/min. We have used both Superdex 200 HR 10/30 and Superdex 200 increase 10/300 columns with similar results though Superdex increase 10/300 columns can be run at higher flow rates. 2. Prepare 300 mL of appropriate initial size exclusion chromatography buffer filtered through a 0.45-μm filter. The precise buffer composition should be selected to stabilize the chromatin complex, a decision that may require iterative optimization. We use 5 mM Tris-Cl pH 7.6, 35-75 mM NaCl, 1 mM DTT, and any complex-specific additives for our initial attempts. When possible, our initial choice of salt concentration is based on quantitative binding experiments using fluorescence quenching HIFI binding experiments in varying conditions (Hieb, D'Arcy, Kramer, White, & Luger, 2012; Kim et al., 2015; McGinty et al., 2014; Winkler, Luger, & Hieb, 2012) . 3. Equilibrate Superdex 200 column in the same chromatography buffer. 4. Plan the recipe for the chromatin complex. For analytical reconstitutions, we typically prepare 400 μL of complex with 0.5-1.0 mg/mL NCP and 2.2-2.5 molar equivalents of a chromatin protein anticipated to bind with a 2:1 chromatin protein:NCP stoichiometry. This corresponds to a slight excess of the chromatin protein to drive saturation. In cases where a 1:1 nucleosome binding is expected, the molar equivalents are halved. Depending on the size and shape of the chromatin protein, the excess chromatin protein can often be separated from the chromatin protein/NCP complex by size exclusion chromatography. An example used to reconstitute the PRC1 ubiquitylation module/ NCP complex is provided here. Fig. 2A and B). 7. Analyze peak fractions by SDS-PAGE using an 18% gel. 8. The quality of complex is assessed as follows:
(a) Examine the width and symmetry of the chromatographic peak of the chromatin complex. A front shoulder often suggests superstoichiometric nonspecific binding to the nucleosome as observed initially with the reconstitution described earlier ( Fig. 2A) . Meanwhile a back shoulder may suggest unsaturated complex or free nucleosome. The presence of a peak for the chromatin protein implies unbound protein resulting from too stringent of reconstitution conditions or too much protein added in the reconstitution mixture. We also plot and examine the A 260 /A 280 ratio that acts as a surrogate for the NCP to chromatin protein ratio (Fig. 2D) . A flat A 260 /A 280 ratio across the chromatin complex peak indicates a homogenous and saturated complex ( Fig. 2E and F) . One can also use the absorbance of a fluorophore attached to the chromatin protein to further interrogate the quality of the complex based on alignment of the fluorophore absorbance and A 260 peaks (Fig. 2F , and see more below). (b) Examine the stoichiometry of the chromatin protein and histones in peak fractions via SDS-PAGE. Homogeneous, saturated complexes show similar stoichiometry across the entire peak as opposed to higher levels of the chromatin protein relative to histones at the front edge of the peak vs the back edge. 9. Based on the above analysis, adjust the reconstitution buffer conditions until a high-quality complex is obtained. For the PRC1 ubiquitylation module-NCP complex described earlier, the NaCl concentration in the reconstitution buffer was systematically increased to 75 mM to eliminate the observed front shoulder indicative of superstoichiometric binding of PRC1 to the NCP ( Fig. 2A and B) . 10. With optimized buffer conditions established, we then optimize the ratio of chromatin protein to nucleosome by repeating analytical reconstitutions followed by size exclusion chromatography, titrating the chromatin protein into the nucleosome. We first use a broad titration series, for example, 1.1:1, 2.2:1, 3.3:1, etc., to determine preferred stoichiometry and to further rule out superstoichiometric binding by examining peak profile and retention time shift upon increasing chromatin protein ( Fig. 2A and D) . This broad titration series can then be refined using a more targeted titration ( Fig. 2B and E) . Again fluorescently labeled chromatin factor can aid in the analysis. Such optimization led us to use 2.8-3.0:1 PRC1 ub module:NCP for preparative scale reconstitutions ( Fig. 2C and F) . Note that at a ratio of 2.8:1 PRC1 ub module:NCP, the A 260 peak (detecting mostly nucleosomal DNA) and the A 525 peak (detecting the fluorescently labeled chromatin enzyme) align, whereas at a ratio of 2.2:1, the two peaks do not align (Fig. 2F ). 11. If the Superdex 200 column will not be used for additional runs, wash the column in water at 0.4 mL/min and then store in 25% ethanol at 0.2 mL/min flow rate.
Preparative Purification
After optimizing the reconstitution on analytical scale, we reconstitute and purify the chromatin complex on a preparative scale. Here, we describe the procedure used in our laboratory to purify chromatin complexes by size exclusion chromatography on preparative scale for crystallization. 4. Purify the chromatin complex by size exclusion chromatography over the equilibrated Superdex 200 column as described earlier for analytical reconstitutions ( Fig. 2C and F) . 5. Pool the chromatin complex (PRC1 ub module/NCP here) Superdex fractions (typically 3-5 fractions of 0.4 mL/fraction, or 1.2-2 mL) in Eppendorf tubes. We often add PMSF to 0.1 mM to minimize proteolysis of the complex.
CONCENTRATE CHROMATIN COMPLEX
1. Concentrate the chromatin complex pool using a Vivaspin 500, 10 kDa cutoff centrifuge concentration device to a final concentration of $10 mg/mL. Use a microcentrifuge speed of 10K rpm or manufacturer's recommended centrifugation speed for all concentration centrifugation steps. For ill-behaved samples, consider concentrating an aliquot to first confirm that the chromatin complex can be concentrated to high concentrations without aggregation before committing the entire sample.
(a) Wash concentration device twice with size exclusion chromatography buffer and discard filtrates. (b) Concentrate chromatin complex pool through successive spins of 400-500 μL until the final volume is less than 150 μL. 5-10 min is usually sufficient to concentrate 500 μL per spin. Substantially, longer centrifugation times may indicate aggregation of the sample in the concentration buffer. Quantitate the chromatin complex. We typically quantitate using the UV absorbance of the nucleic acid component of the NCP within the chromatin complex under denaturing basic conditions to dissociate the chromatin and histone proteins from the nucleosomal DNA. With some complexes, we do not observe a clear peak at 260 nm. Rather the absorbance continues to increase at lower wavelengths. In such cases, quantitation using this protocol can lead to overestimation of complex concentration. Additionally, when using chromatin proteins with significant absorption at 260 nm, this protocol will need to be adjusted accordingly. The extinction coefficient was adjusted from that of DNA in neutral pH conditions based on empirical measurements. We have observed that this calculation can occasionally overestimate the chromatin complex concentration, so it is best to consider the calculated chromatin complex concentration as an estimate and not a firm measurement. (e) Calculate the purification yield of the chromatin complex based on the limiting reagent when reconstituting the chromatin complex (in this example, the NCP). For example: (i) started with 1.55 mg of NCP complex, equivalent to 7.59 nmol for the 204,921 Da NCP (ii) ended with 100 μL of PRC1 ub module/NCP complex @ 13.5 mg/mL, or 4.65 nmol PRC1 ub module/NCP complex (iii) purification yield ¼ 4.65/7.59 ¼ 61.3% (yields are typically between 50% and 80%) 3. Use the chromatin complex immediately for crystallization trials, or store complex on ice in cold room, or where appropriate, add glycerol to 20%, flash freeze in liquid nitrogen, and store at À80°C.
CRYSTALLIZE CHROMATIN COMPLEX
Crystallization
Standard crystallization approaches can be used to crystallize the chromatin complex. As with purification of chromatin proteins, the process of crystallizing a chromatin complex is highly variable and dependent on the properties of the individual complex. Nevertheless, basic principles and concepts will apply to the crystallization of many chromatin complexes, and we share such ideas here: 1. As with most any crystallization trial, one should survey a range of pH, salt, and precipitating conditions. Since many chromatin complexes are sensitive to salt, it may be prudent to bias toward low salt conditions and near neutral pH. These conditions can be fulfilled by commercial low ionic strength crystallization screens and screens for protein-nucleic acid complexes (Hampton Natrix Screens, Hollis Lab Protein-Nucleic Acid Complex Crystal Screen (Pryor, Wozniak, & Hollis, 2012) ).
3. Divalent ions can play different roles in chromatin complex crystallization. Magnesium ions (Mg 2+ ) are often used in protein/nucleic acid cocrystallization. However, Mg 2+ is also used to condense chromatin (Fredericq, Hacha, Colson, & Houssier, 1991) , and NCPs are crystallized at the salting in transition balancing Mn 2+ as a precipitating agent and KCl as a solubilizing agent (Hanson, Alexander, Harp, & Bunick, 2004; Luger, Mäder, Richmond, Sargent, & Richmond, 1997; Rhodes, Brown, & Klug, 1989) . As such, use of millimolar concentrations of Mg 2+ in the crystallization trials could favor precipitating the chromatin complex instead of controlled crystallization. It should be noted, however, that the Sir3 silencing protein was crystallized with NCPs in the presence of 10 mM MgCl 2 (Armache et al., 2011) . 4. As with crystallizing any protein, the use of orthologous proteins can be a fruitful strategy. In the case of the RCC1/nucleosome complex, initial crystals were grown using human RCC1, but the crystals were hollow and produced very poor diffraction. Substituting yeast RCC1 (Srm1) produced morphologically more perfect crystals, but nonisotropic diffraction of X-rays limited to about 7 Å in the worse directions. On the other hand, Drosophila RCC1 (Bj1) complexed with the nucleosome produced crystals with both external and internal order, permitting diffraction data collection to 2.9 Å (Makde et al., 2010; Makde & Tan, 2013) .
Fluorescent Labeling of Chromatin Protein for Cocrystallization with the Nucleosome
One recurrent challenge we observe in the crystallization of chromatin complexes is the undesired crystallization of subcomplexes. This is especially true when working with chromatin proteins bound to the NCP, where the nucleosome particle often crystallizes without the chromatin protein bound. This can lead to much time wasted optimizing false leads to obtain crystals that are large enough to verify their contents by SDS-PAGE. To short circuit this problem and streamline crystal screening, we use fluorescently labeled chromatin proteins during screening. This allows us to verify the presence of the chromatin protein in any crystallization hits in situ, following procedures developed more generally for protein crystallization (Meyer, Betzel, & Pusey, 2015; Pusey et al., 2015) . We label our chromatin proteins through the N-α amino group using 5-(and-6)-carboxyrhodamine 6G, succinimidyl ester using pH conditions that favor conjugation specifically at the N-terminus. This fluorophore is small and inexpensive and has stable spectrophotometric properties over a wide range of pHs often used in crystallization screens. The N-terminal labeling is convenient and unlikely to interfere with crystallization as terminal regions of proteins are often unstructured in macromolecular crystals. Of note, it is possible that some nonspecific labeling of lysine side chain amines may occur in this pH-controlled reaction. However, at labeling percentages under 2% of the total chromatin protein pool, any resulting heterogeneity is minimal. Moreover, if undesired side chain modification of the chromatin protein prevents nucleosome binding, the improperly labeled protein is often purified away from the chromatin complex during size exclusion chromatography and at trace levels causes little to no change of the overall chromatin protein to nucleosome ratio. This methodology can also be applied to other fluorophores and conjugation chemistries.
An example of fluorescent labeling of a chromatin protein and incorporation into a chromatin complex is shown here. 1. Prepare your chromatin protein for labeling. In order to achieve efficient labeling of the chromatin protein, reactive nucleophiles (especially primary amines) that can consume the fluorophore must be removed or minimized. Buffer exchange can be performed by dialysis, size exclusion chromatography, or through a desalting column. Additionally, if the chromatin protein is sufficiently concentrated, dilution into labeling buffer may be adequate given the low levels of labeling required. In anticipation of labeling requirements, the chromatin protein can often be concentrated in a suitable buffer for labeling. 2. We typically label 2-5 mg of chromatin protein at 1-4 mg/mL. An example of labeling the PRC1 ubiquitylation module is shown here. 6. The chromatin complex can be purified, concentrated, quantitated, and used in crystallization screens as described earlier for the unlabeled complex. We record the A 525 along with the A 260 and A 280 during size exclusion chromatography. This allows us to visualize the alignment of the chromatin protein (A 525 ) and NCP (A 260 ) independently to confirm saturation of the chromatin complex (Fig. 2C ). 7. Observe fluorescence of crystals. We observed crystals grown with fluorescently labeled chromatin complexes using a Nikon SM7 1500 stereoscope equipped with a Nikon Intensilight C-HGFI light source, a DsRed filter (Ex 545/30 nm, DM 570 nm, BA 620/60 nm), and a CoolSnapEZ Turbo 1394 camera.
POSTCRYSTALLIZATION SOAKS TO IMPROVE DIFFRACTION
Postcrystallization soaks of chromatin complex crystals appear to be particularly important for obtaining high-resolution diffraction. This is consistent with the previous observations that the order within NCP crystals could be improved by postcrystallization soaks in methylpentanediol (MPD) or other alcohols (Richmond, Finch, Rushton, Rhodes, & Klug, 1984; Struck, Klug, & Richmond, 1992) . Therefore, it is highly advisable to spend significant efforts exploring postcrystallization soaking conditions once chromatin complex crystals have been grown, assuming of course that sufficient numbers of such crystals can be grown.
The underlying approach is to find a base soaking solution in which the crystal is stable, and then to gradually increase the concentration of the additive, usually a dehydration agent. We usually perform this procedure using loops to transfer crystals between drops of different compositions, but one can imagine other procedures using dialysis buttons or diffusing volatile reagents. One should also consider using dehydration equipment such as the HC-1 device developed at EMBL Grenoble, which may provide a more reproducible and direct way of manipulating the hydration state of macromolecular crystals (Bowler et al., 2015; Sanchez-Weatherby et al., 2009; Wheeler, Russi, Bowler, & Bowler, 2012) . 1. Determine a crystallization base soaking solution in which the crystal is stable. We usually start with the precipitant used in the relevant crystallization trial and increase the precipitant concentration by 1.25 fold (though older crystallization drops may need higher precipitant concentrations). So, for example, if the precipitant contained 20 mM Tris-Cl pH 7.6, 50 mM NaAc, and 6% PEG2000-MME, we would use 20 mM Tris-Cl pH 7.6, 50 mM NaAc, and 7.5% PEG2000-MME as the trial crystallization base soaking solution.
Transfer a small crystal into the trial crystallization base soaking solution and observe the crystal under a microscope. If the crystal dissolves, it is likely that the precipitant concentration needs to be increased, although the pH or the salt concentration might have to be manipulated as well. If the crystal cracks, it is likely the precipitant concentration needs to be decreased. The trial crystallization base soaking solution is ideally one in which the crystal is stable for at least 15 min at the appropriate temperature. We usually perform soaking experiments at room temperature, but we did observe that soaking RCC1/nucleosome crystals at 4°C was important for obtaining high-resolution diffraction (Makde & Tan, 2013) . 2. Determine a soaking protocol that permits the additive to be soaked into the crystal without damaging the external morphology of the crystal. . If cracking or defects are observed during the process, continue with the procedure for at least two more additive additions. It is not uncommon to observe cracking or defects followed by annealing of these cracks or defects upon further soaks, reflecting repacking of the molecules in the crystal. (e) Where appropriate, flash cool the crystal by plunging into liquid nitrogen before storage in liquid nitrogen. Notes:
(i) Unfortunately, there is no simple soaking protocol that will handle all cases. The appropriate protocol needs to be determined empirically. Potentially important variables include the identity of the soaking additive, the final concentration of the soaking additive, the number of steps used to reach the final concentration of the soaking additive, the method used to achieve such steps (eg, transfer via loops), the soaking temperature, and the soaking time per step.
(ii) Since the ultimate criteria of judging success of a soaking protocol are the quality of X-ray diffraction and since one will want to examine many soaking protocols, one approach is to process many crystals through the various soaking protocols and to then examine the diffraction in succession at a home or synchrotron source. (iii) It is advisable to examine a variety of dehydration soaking agents including but not necessarily limited to MPD, PEG400, PEG2000, and PEG550-MME. (iv) You can assess the maximum concentration for an additive by increasing the concentration of the additive until the crystals show defects that do not anneal with further additions of the additive. (v) The soaking protocol can manipulate more than one additive, perhaps to introduce a cryoprotectant as well as a dehydrating agent. For example, you could increase both glycerol and PEG400 conditions simultaneously or in succession. (vi) Make sure to allow enough time for the crystal to equilibrate against the soaking solution, particularly for the final soak. This may be particularly important for the reproducibility of the soaking protocol. (vii) We have observed that postcrystallization protocols optimized for crystals harvested from fresh drops do not necessarily work with crystals harvested from older crystallization drops. (viii) One may wish to decrease the incremental step of the dehydrating agent or additive in the soaking solutions to achieve more gradual dehydration. For example, we used 2% steps of PEG400 when dehydrating RCC1/nucleosome crystals (Makde et al., 2010; Makde & Tan, 2013) .
